Venus Remedies P/B Ratio
Venus Remedies (VENUSREM) P/B ratio is 3.45 (High), book value per share ₹510.77 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. View VENUSREM 52-week high low for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
VENUSREM P/B Ratio — Valuation Insights & Book Value Analysis
Venus Remedies price-to-book ratio interpretation, valuation status and historical context — current P/B 3.45 (High). Review VENUSREM price earnings ratio to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 3.45, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 130.0% above historical average
- Trading at premium to sector average PB of -0.33
Venus Remedies P/B Ratio Historical Trend
VENUSREM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Venus Remedies share price today.
VENUSREM Historical P/B Ratio — Book Value Per Share & Year-End Price
Venus Remedies annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 3.36 | ₹510.77 | ₹1715.10 | ₹664 | High |
| 2025 | 1.6 | ₹431.54 | ₹691.15 | ₹561 | Moderate |
| 2024 | 0.85 | ₹375.38 | ₹320.15 | ₹488 | Low |
| 2023 | 1.15 | ₹353.85 | ₹405.95 | ₹460 | Moderate |
| 2022 | 0.54 | ₹338.46 | ₹181.15 | ₹440 | Low |
VENUSREM vs Healthcare Peers — P/B Ratio Comparison
Venus Remedies P/B 3.45 vs Healthcare average -0.33, median 0.6 — range -17.45–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |